Literature DB >> 15967863

Heart failure devices: implantable cardioverter-defibrillators and biventricular pacing therapy.

Alan Kadish1, Mandeep Mehra.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15967863     DOI： 10.1161/CIRCULATIONAHA.104.481267

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

Review 1.  Indications for implantable cardioverter-defibrillator placement in ischemic cardiomyopathy and after myocardial infarction.

Authors:  Stavros E Mountantonakis; Mathew D Hutchinson
Journal:  Curr Heart Fail Rep       Date:  2011-12

2.  Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry.

Authors:  Dan D Matlock; Pamela N Peterson; Yongfei Wang; Jeptha P Curtis; Matthew R Reynolds; Paul D Varosy; Frederick A Masoudi
Journal:  Arch Intern Med       Date:  2012-04-23

3.  Primary ICD-therapy in patients with advanced heart failure: selection strategies and future trials.

Authors:  Lutz Frankenstein; Christian Zugck; Manfred Nelles; Dieter Schellberg; Andrew Remppis; Hugo Katus
Journal:  Clin Res Cardiol       Date:  2008-03-17       Impact factor: 5.460

4.  Imaging of the coronary venous system in patients with congestive heart failure: comparison of 16 slice MSCT and retrograde coronary sinus venography: comparative imaging of coronary venous system.

Authors:  Christian Knackstedt; Georg Mühlenbruch; Karl Mischke; Thomas Schimpf; Elmar Spüntrup; Rolf W Günther; Beyhan Sanli; Malte Kelm; Patrick Schauerte; Andreas H Mahnken
Journal:  Int J Cardiovasc Imaging       Date:  2008-07-09       Impact factor: 2.357

5.  Shedding Light on the Black Box: Explaining Deep Neural Network Prediction of Clinical Outcomes.

Authors:  Yijun Shao; Yan Cheng; Rashmee U Shah; Charlene R Weir; Bruce E Bray; Qing Zeng-Treitler
Journal:  J Med Syst       Date:  2021-01-04       Impact factor: 4.460

6.  Contrast-enhanced whole-heart coronary MRA at 3.0T for the evaluation of cardiac venous anatomy.

Authors:  Heng Ma; Qing Tang; Qi Yang; Xiaoming Bi; Han Li; Lan Ge; Kai Lin; Dong Xu; Xiangying Du; Jie Lu; Jing An; Lixin Jin; Renate Jerecic; Kuncheng Li; Debiao Li
Journal:  Int J Cardiovasc Imaging       Date:  2010-12-01       Impact factor: 2.357

7.  Clinical Course After Cardioverter-Defibrillator Implantation: Chagasic Versus Ischemic Patients.

Authors:  Francisca Tatiana Moreira Pereira; Eduardo Arrais Rocha; Marcelo de Paula Martins Monteiro; Neiberg de Alcantara Lima; Carlos Roberto Martins Rodrigues Sobrinho; Roberto da Justa Pires Neto
Journal:  Arq Bras Cardiol       Date:  2016-07-11       Impact factor: 2.000

Review 8.  New Era of Electroceuticals: Clinically Driven Smart Implantable Electronic Devices Moving towards Precision Therapy.

Authors:  RaviPrakash Magisetty; Sung-Min Park
Journal:  Micromachines (Basel)       Date:  2022-01-22       Impact factor: 2.891

9.  Ranolazine preserves and improves left ventricular ejection fraction and autonomic measures when added to guideline-driven therapy in chronic heart failure.

Authors:  Gary L Murray; Joseph Colombo
Journal:  Heart Int       Date:  2014-12-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.